Premier Research, a clinical research company, has named Cassandra Matney, MD as its new senior medical director, it was reported on Monday.
Matney has experience in both solid and haemato-oncology tumours. Her therapeutic work in haematology and oncology includes prostate cancer, acute myeloid leukaemia, multiple myeloma, myeloproliferative neoplasms, myelodysplastic syndromes, B-cell malignancies, urothelial/bladder cancer, gastric/gastroesophageal cancer, and graft versus host disease.
Most recently, Matney managed medical affairs positions at Astellas Pharmaceuticals Global Development Inc, Janssen Oncology (a pharmaceutical company of Johnson & Johnson), and Incyte Corporation. She has also served as CRO and has site experience working at both Covance and academic centre Meharry Medical College, respectively.
Matney holds a medical degree at the Universidad Autonoma de Guadalajara and New York Medical College, and a Bachelor of Science degree from Illinois State University. She is certified by the Educational Commission for Foreign Medical Graduates.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business